MABVAX THERAPEUTICS INC — Form D
MABVAX THERAPEUTICS INC of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-07-10. The offering totals $10.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-07-10
- Form: D
- Accession: 0001429968-14-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $3.0M
- Remaining: $7.0M
- Investors: 23
- Date of first sale: 2014-07-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-220687
Issuer
- Name: MABVAX THERAPEUTICS INC
- CIK: 0001429968
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: 11588 SORRENTO VALLEY ROAD, SAN DIEGO, CA, 92121
- Phone: 858-259-9405
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Jim J Antonopoulos | Director | San Diego, CA |
| Kenneth M Cohen | Director | SAN DIEGO, CA |
| J. David Hansen | Director | San Diego, CA |
| Philip O Livingston | Director | San Diego, CA |
| Paul M Maier | Director | San Diego, CA |
| Jeffrey V Ravetch | Director | San Diego, CA |
| J. David Hansen | Executive Officer | San Diego, CA |
| Gregory P Hanson | Executive Officer | San Diego, CA |
| Philip O Livingston | Executive Officer | San Diego, CA |
| Philip Livingston | Director | San Diego, CA |
| James David Antonopoulos | Director | San Diego, CA |
| Douglas D Lind | Director | San Diego, CA |
| Nick Stephens | Director | San Diego, CA |
Other filings by this issuer (2)
More